 Connection
Danielle Cooke to Sclerotherapy
This is a "connection" page, showing publications Danielle Cooke has written about Sclerotherapy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.379 |
|
|
|
-
Hirabayashi KE, Kalin-Hajdu E, Bever GJ, Vagefi MR, de Alba Campomanes AG, Cooke DL, Dowd CF, Kersten RC. Normalization of Congenital Venous Stasis Retinopathy Following Sclerotherapy of a Macrocystic Lymphatic Malformation. Ophthalmic Plast Reconstr Surg. 2018 Jan/Feb; 34(1):e19-e21.
Score: 0.148
-
Settecase F, Hetts SW, Nicholson AD, Amans MR, Cooke DL, Dowd CF, Higashida RT, Halbach VV. Superselective Intra-Arterial Ethanol Sclerotherapy of Feeding Artery and Nidal Aneurysms in Ruptured Cerebral Arteriovenous Malformations. AJNR Am J Neuroradiol. 2016 Apr; 37(4):692-7.
Score: 0.128
-
Caton MT, Duvvuri M, Baker A, Smith ER, Narsinh KH, Amans MR, Hetts SW, Higashida RT, Cooke DL, Dowd CF. Percutaneous sclerotherapy for head and neck lymphatic malformations in neonates and infants =12 months of age. J Neurointerv Surg. 2023 Dec; 15(12):1242-1246.
Score: 0.052
-
Caton MT, Baker A, Smith ER, Perez E, Hemphill K, Cooke DL, Dowd CF. Dual-agent percutaneous sclerotherapy technique for macrocystic lymphatic malformations. J Neurointerv Surg. 2023 Sep; 15(9):931.
Score: 0.051
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|